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Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Stacy A. Malaker, Sarah A. Penny, Lora G. Steadman, Paisley T. Myers, Justin C. Loke, Manoj Raghavan, Dina L. Bai, Jeffrey Shabanowitz, Donald F. Hunt, and Mark Cobbold The identification of neoepitopes expressed by tumors will aid the effectiveness of antitumor therapies. Four classes of posttranslationally modified tumor neoantigens were identified on primary tumors. Healthy donors had detectable natural immunity to a subset of these. To request permission to re-use all or part of this article, contact the AACR Publications Department at
